To explore the mechanism of resistance to naquotinib, we established multiple naquotinib-resistant lung cancer cell lines from EGFR-TKI-naïve or EGFR-TKI pre-exposed resistant cells, and we performed a comprehensive analysis, which included next-generation sequencing. The gene discussed is EGFR; the disease is lung carcinoma.